Conflicting results are reported for inflammasome activation via the “canonical pathway” involving caspase 1 functions in stable COPD patients [24,25], which were found to be upregulated by some authors [24] or not changed by others [25]. Here, CASP1 is linked to chronic obstructive pulmonary disease.